Feasibility study of postoperative adjuvant chemotherapy with S-1 (tegaful, gimeracil, oteracil potassium) for non-small cell lung cancer—LOGIK 0601 study

Lung Cancer ◽

10.1016/j.lungcan.2009.03.028 ◽

2010 ◽

Vol 67 (2) ◽

pp. 184-187 ◽

Author(s):

Tokujiro Yano ◽

Koji Yamazaki ◽

Riichiroh Maruyama ◽

Shoji Tokunaga ◽

Fumihiro Shoji ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Feasibility Study ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S‐1 in patients with stage II‐IIIA non‐small cell lung cancer

The Journal of Medical Investigation ◽

10.2152/jmi.65.90 ◽

2018 ◽

Vol 65 (1.2) ◽

pp. 90-95 ◽

Author(s):

Mitsuhiro Tsuboi ◽

Kazuya Kondo ◽

Hiromitsu Takizawa ◽

Naoya Kawakita ◽

Toru Sawada ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Feasibility Study ◽

Cell Lung Cancer ◽

Stage Ii ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients

Journal of Chemotherapy ◽

10.1080/1120009x.2019.1651002 ◽

2019 ◽

Vol 31 (6) ◽

pp. 343-348 ◽

Author(s):

Masayoshi Inoue ◽

Hidenori Kusumoto ◽

Hiroyuki Shiono ◽

Yasushi Shintani ◽

Naoko Ose ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy ◽

Lung Cancer Patients

Download Full-text

21 Adjuvant chemotherapy in Non Small Cell Lung Cancer (NSCLC) —a feasibility study in the non-trial population

Lung Cancer ◽

10.1016/s0169-5002(07)70347-1 ◽

2007 ◽

Vol 57 ◽

pp. S6

Author(s):

S.J. Treece ◽

L. Magee ◽

D. Gilligan ◽

S.V. Harden

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Feasibility Study ◽

Cell Lung Cancer ◽

Small Cell Lung

Download Full-text

Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1139-x ◽

2009 ◽

Vol 66 (1) ◽

pp. 107-112 ◽

Author(s):

Masafumi Yamaguchi ◽

Sadanori Takeo ◽

Ryuichi Suemitsu ◽

Hironori Matsuzawa

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Feasibility Study ◽

Cell Lung Cancer ◽

Small Cell Lung

Download Full-text

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer

OncoTargets and Therapy ◽

10.2147/ott.s88700 ◽

2015 ◽

pp. 2033 ◽

Author(s):

Bin Xiong ◽

Yuan-Yuan Chen ◽

Lin-Wei Wang ◽

Shu-Yi Wang ◽

Bi-Bo Wu ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Meta Analysis ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer

Current Opinion in Oncology ◽

10.1097/01.cco.0000208787.91947.a2 ◽

2006 ◽

Vol 18 (2) ◽

pp. 144-150 ◽

Author(s):

Katsuyuki Hotta ◽

Keitaro Matsuo ◽

Katsuyuki Kiura ◽

Hiroshi Ueoka ◽

Mitsune Tanimoto

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

Randomized study on the usefulness of etoposide, UFT, Ubenimex as a postoperative adjuvant chemotherapy for non-small cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(91)91784-9 ◽

1991 ◽

Vol 7 ◽

pp. 117

Author(s):

N. Shimizu ◽

A. Ando ◽

S. Teramoto ◽

K. Ono ◽

Y. Nakajima ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

Lack of predictive value of reticulocalbin-1 and GST-Pai alterations for efficacy of postoperative adjuvant chemotherapy consisting of cisplatin plus vindesine in patients with p-stage IIIA-N2 non-small cell lung cancer (NSCLC) (JCOG9304A)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7316 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7316-7316

Author(s):

M. Tsuboi ◽

T. Hirano ◽

T. Ohira ◽

H. Kato ◽

T. Mitsudomi ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Predictive Value ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy

Download Full-text

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyw062 ◽

2016 ◽

Vol 46 (8) ◽

pp. 741-747 ◽

Author(s):

Junichi Soh ◽

Norihito Okumura ◽

Masao Nakata ◽

Hiroshige Nakamura ◽

Minoru Fukuda ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Feasibility Study ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Cancer Group ◽

Stage Ia ◽

Download Full-text

Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I–II NSCLC (non-small cell lung cancer): a randomized clinical trial1

European Journal of Cardio-Thoracic Surgery ◽

10.1016/s1010-7940(99)00031-7 ◽

1999 ◽

Vol 15 (4) ◽

pp. 438-443 ◽

Author(s):

Hiromi Wada ◽

Ryo Miyahara ◽

Fumihiro Tanaka ◽

Shigeki Hitomi ◽

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Stage I ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy ◽

Download Full-text